Centre tells Serum Institute, Bharat biotech to lower their Covid vaccine prices

SII along with British pharmaceutical company AstraZeneca is producing Covishield while Bharat Biotech is making Covaxin in collaboration with the Indian Council of Medical Research (ICMR).
Both Covishield and Covaxin were granted approval for emergency use by the Drugs Controller General of India (DGCI) on January 3 this year.(Keshav Singh/HT file photo)
Both Covishield and Covaxin were granted approval for emergency use by the Drugs Controller General of India (DGCI) on January 3 this year.(Keshav Singh/HT file photo)
Updated on Apr 26, 2021 07:32 PM IST
Copy Link
By | Written by Harshit Sabarwal, New Delhi

The central government on Monday asked the Serum Institute of India (SII) and Bharat Biotech to lower the prices of their vaccines against the coronavirus disease (Covid-19) ahead of the third phase of the nationwide vaccination drive from May 1, news agency PTI reported citing sources. Monday’s request by the Centre came after a row erupted over the vaccine prices ahead of the third phase of the vaccination drive from May 1, when all adults will be eligible for the jabs.

SII along with British pharmaceutical company AstraZeneca is producing Covishield while Bharat Biotech is making Covaxin in collaboration with the Indian Council of Medical Research (ICMR). Both the vaccines were granted approval for emergency use by the Drugs Controller General of India (DGCI) on January 3 this year.

Also Read| 141.9 million Covid-19 vaccine doses administered till date: Govt

Under the third phase, there will be two segments with regard to the supply of doses—vaccine manufacturers will supply 50 per cent of their monthly Central Drugs Laboratory (CDL) doses to the central government and will also be free to supply the remaining 50 per cent doses to the states and in the open market. State government hospitals and private hospitals can now directly purchase vaccine doses from the manufacturers.

SII has said Covishield will be sold to states at 400 per dose while private hospitals will have to pay 600 per dose. Covaxin will be sold at 600 per dose to the state government hospitals and 1,200 for private hospitals, Bharat Biotech has said. However, the central government will purchase doses of both vaccines at 150 per dose.

Also Read| ‘No reason why states must complain now’: Vardhan’s clarification on vaccination

This led to the leaders of several opposition parties slamming the central government of procuring vaccine doses at cheaper prices and also accused the manufacturers of profiteering from it.

However, dismissing all allegations, Union health minister Dr Harsh Vardhan said on Sunday the central government will continue to give vaccine doses from its 50 per cent quota to the states and Union Territories (UTs) free of cost. In a four-page letter, Vardhan added this quota is also open for the private and the corporate sector to pool in their resources so that the combined effort can be deployed to inoculate every adult in this country in the earliest possible time.

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, May 27, 2022